## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
β¦ LIBER β¦
ChemInform Abstract: Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy
β Scribed by R. R. WEXLER; W. J. GREENLEE; J. D. IRVIN; M. R. GOLDBERG; K. PRENDERGAST; R. D. SMITH; P. B. M. W. M. TIMMERMANS
- Book ID
- 112032226
- Publisher
- John Wiley and Sons
- Year
- 2010
- Weight
- 25 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
ChemInform Abstract: The Development of
β
H.-D. HOELTJE; G. JESSEN; M. HOELTJE
π
Article
π
2010
π
John Wiley and Sons
β 24 KB
π 2 views
ChemInform Abstract: Pilot Scale Synthes
ChemInform Abstract: Pilot Scale Synthesis of a Novel Nonpeptide Angiotensin II Receptor Antagonist.
β
A. ZANKA; M. NISHIWAKI; Y. MORINAGA; T. INOUE
π
Article
π
2010
π
John Wiley and Sons
β 38 KB
π 2 views
ChemInform Abstract: A New Class of Diac
β
Takehiko Naka; Keiji Kubo
π
Article
π
2010
π
John Wiley and Sons
β 25 KB
π 2 views
Antihypertensive activity of a nonpeptid
β
Masayuki Shibasaki; Akira Fujimori; Toshiyuki Kusayama; Tomoko Tokioka; Yasuko S
π
Article
π
1997
π
Elsevier Science
π
English
β 382 KB
ChemInform Abstract: Nonpeptide Angioten
β
N. UEYAMA; T. YANAGISAWA; T. KAWAI; M. SONEGAWA; H. BABA; S. MOCHIZUKI; K. KOSAK
π
Article
π
2010
π
John Wiley and Sons
β 29 KB
Advances in antihypertensive therapy: No
β
Julian Smith; Amal Wahhab; John Hondrelis; Renee Ganter; Diana Moore; John M. Ma
π
Article
π
1996
π
Springer Netherlands
π
English
β 301 KB
The development of drugs that selectively block angiotensin receptors has resulted largely from a process of trialand-error medicinal chemistry on an early lead. The new generation of angiotensin antagonists or angiotensin mimetics are essentially devoid of side effects and are set to replace the an